# Uterine Fibroid (Leiomyoma)

## Definition

- **Benign monoclonal tumor of smooth muscle** origin from the **myometrium**
- Estrogen and progesterone sensitive
- Most common **pelvic tumor** in reproductive-age women
- Can be **single or multiple**, and vary in size/location

## Types by Location

1. **Intramural** – within myometrium (most common)
2. **Submucosal** – projects into endometrial cavity
3. **Subserosal** – projects outward from uterus
4. **Pedunculated** – attached by stalk (submucosal or subserosal)
5. **Cervical** – arising from cervix

## Clinical Features

### A. Symptoms

- **Menstrual problems**

  - Menorrhagia (most common)
  - Dysmenorrhea
  - Metrorrhagia (if submucosal)

- **Pressure symptoms**

  - **Bladder** → urinary frequency, urgency, retention
  - **Rectum** → constipation, tenesmus

- **Reproductive issues**

  - Infertility
  - Miscarriage
  - Preterm labour

- **Mass effects**

  - Abdominal lump/fullness
  - Pain (degeneration, torsion)

- **Systemic**

  - Pallor (due to anemia from heavy bleeding)

### B. Signs

- **Abdominal Exam**

  - Firm, irregular, non-tender mass in suprapubic area
  - Uterus enlarged to variable "pregnancy size"

- **Bimanual Vaginal Exam**

  - Enlarged, firm uterus
  - Limited mobility if large
  - Cervix may be displaced

## Investigations

### A. For Diagnosis

1. **Transvaginal and Transabdominal Ultrasound**

   - **Findings**:

     - Enlarged uterus with well-defined, hypoechoic mass
     - May have calcifications (echogenic foci)
     - Shadowing, distortion of endometrial stripe (esp. submucosal)
     - Multiple lesions → heterogenous myometrium

2. **Saline Infusion Sonohysterography (SIS)**

   - Better for **submucosal fibroid** detection

3. **MRI**

   - Better for surgical planning
   - Differentiates fibroids from adenomyosis

4. **Hysteroscopy**

   - Direct visualization of **submucosal fibroids**

### B. For Complications

- **CBC** → anemia from menorrhagia
- **Renal function** → if hydronephrosis suspected (pressure effect)
- **Urinalysis** → if urinary symptoms present

### C. For Exclusion of Other Causes

- **Pregnancy test** → always in reproductive age
- **Endometrial biopsy** → in perimenopausal women with bleeding (rule out malignancy)

## Complications

### A. Menstrual & Hematologic

- **Anemia** from chronic blood loss
- Iron deficiency

### B. Reproductive

- **Infertility** (esp. submucosal)
- **Recurrent miscarriage**
- **Preterm labour**
- **Malpresentation**
- **Obstructed labour**

### C. Degenerative Changes

(esp. in large fibroids or pregnancy)

- **Red degeneration** (painful, necrotic, seen in pregnancy)
- **Hyaline degeneration**
- **Cystic/Calcific degeneration**

### D. Mechanical/Pressure

- **Urinary**: Retention, frequency, hydronephrosis
- **Bowel**: Constipation, tenesmus
- **DVT**: Due to pelvic vein compression

### E. Torsion

- Especially in pedunculated subserosal fibroids → acute abdomen

### F. Malignant Change

- Very rare (\<0.1%) → **leiomyosarcoma**

## Management

### General Principles

- Depends on:

  - **Symptoms**
  - **Size & location of fibroid**
  - **Patient’s age**
  - **Desire for fertility**
  - **Suspicion of malignancy**

### 1. Expectant (Conservative) Management

#### Indications

- Asymptomatic
- Small fibroids
- Perimenopausal (may regress after menopause)

#### Plan

- Reassure and monitor
- **Follow-up USG** every 6–12 months
- **Treat anemia** (if present)

---

### 2. Medical Management

#### A. For Menorrhagia / Symptom Control

| Drug                                  | Mechanism                 | Use                          |
| ------------------------------------- | ------------------------- | ---------------------------- |
| **Tranexamic acid**                   | Antifibrinolytic          | Menorrhagia                  |
| **NSAIDs (e.g., mefenamic acid)**     | ↓ Prostaglandins          | Dysmenorrhea, bleeding       |
| **Combined OCPs**                     | Hormonal cycle regulation | ↓ Bleeding                   |
| **Progestins (e.g., norethisterone)** | Endometrial suppression   | ↓ Menstrual flow             |
| **LNG-IUS (Mirena)**                  | Local progestin effect    | ↓ Menorrhagia, contraceptive |

#### B. Fibroid-Specific Hormonal Agents

| Drug                                 | Action                          | Notes                                   |
| ------------------------------------ | ------------------------------- | --------------------------------------- |
| **GnRH agonists (e.g., leuprolide)** | ↓ Estrogen → fibroid shrinkage  | Temporary; pre-op use                   |
| **Ulipristal acetate** (SPRMs)       | Progesterone receptor modulator | Now restricted due to liver injury risk |

---

### 3. Surgical Management

#### A. Myomectomy** – **Fibroid removal with uterus preservation

##### Indications

- Women desiring fertility
- Large symptomatic fibroid
- Submucosal fibroid causing infertility

##### Types

- **Hysteroscopic** (submucosal, ≤5 cm)
- **Laparoscopic** (multiple ≤10 cm, few)
- **Open (abdominal)** – large or multiple fibroids

---

#### B. Hysterectomy** – **Definitive treatment

##### Indications

- Completed family
- Large/multiple symptomatic fibroids
- Failed medical therapy
- Severe pressure symptoms
- Recurrent anemia

##### Types

- **TAH (total abdominal hysterectomy)** ± BSO
- **Vaginal** or **laparoscopic** (selected cases)

---

### 4. Minimally Invasive/Alternative Options

#### A. Uterine Artery Embolization (UAE)

- Blocks blood supply → fibroid shrinkage

##### Indications

- Symptomatic fibroids, not desiring fertility
- Poor surgical candidates

#### B. High-Intensity Focused Ultrasound (HIFU)

- MRI-guided focused thermal destruction
- Limited availability

---

### 5. In Pregnancy

- **Expectant management preferred**
- **Red degeneration** → supportive (bed rest, analgesia)
- **Surgery avoided unless complications**

---

### Summary of Management by Scenario

| Scenario                                  | Management                            |
| ----------------------------------------- | ------------------------------------- |
| **Asymptomatic, small**                   | Observe + follow-up                   |
| **Menorrhagia**                           | NSAIDs, tranexamic acid, LNG-IUS, OCP |
| **Wants fertility**                       | Myomectomy (lap/open/hysteroscopic)   |
| **No fertility desire, completed family** | Hysterectomy                          |
| **Poor surgical candidate**               | UAE                                   |
| **Large fibroid before surgery**          | GnRH agonist (pre-op shrinkage)       |
| **Red degeneration in pregnancy**         | Analgesics, fluids, rest              |
